BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11932486)

  • 1. Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness.
    Cothren C; Moore EE; Offner PJ; Haenel JB; Johnson JL
    N Engl J Med; 2002 Apr; 346(14):1097-8. PubMed ID: 11932486
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined blood substitute and erythropoietin therapy in a severely injured Jehovah's Witness.
    Hardy JF; BĂ©lisle S; Van der Linden P
    N Engl J Med; 2002 Aug; 347(9):696-7; author reply 696-7. PubMed ID: 12200566
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe anemia in the Jehovah's Witness: case report and discussion.
    Collins SL; Timberlake GA
    Am J Crit Care; 1993 May; 2(3):256-9. PubMed ID: 8364678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating severe anemia in a trauma patient who is a Jehovah's witness.
    Gilcreast DM; Avella P; Camarillo E; Mullane G
    Crit Care Nurse; 2001 Apr; 21(2):69-72, 75-8, 80-2. PubMed ID: 11858442
    [No Abstract]   [Full Text] [Related]  

  • 5. Jehovah's Witnesses: unique problems in a unique trauma population.
    Victorino G; Wisner DH
    J Am Coll Surg; 1997 May; 184(5):458-68. PubMed ID: 9145065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large volume polymerized haemoglobin solution in a Jehovah's Witness following abruptio placentae.
    Cothren CC; Moore EE; Long JS; Haenel JB; Johnson JL; Ciesla DJ
    Transfus Med; 2004 Jun; 14(3):241-6. PubMed ID: 15180817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful use of a polymerized hemoglobin blood substitute in a critically anemic Jehovah's Witness.
    Allison G; Feeney C
    South Med J; 2004 Dec; 97(12):1257-8. PubMed ID: 15646766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of erythropoietin in Jehovah's Witness patients.
    Jim RT
    Hawaii Med J; 1990 Jun; 49(6):209. PubMed ID: 2397990
    [No Abstract]   [Full Text] [Related]  

  • 9. Extreme anemia in an injured Jehovah's Witness: a test of our understanding of the physiology of severe anemia and the threshold for blood transfusion.
    Vaziri K; Roland JC; Robinson LL; Reines HD; Fakhry SM
    J Trauma; 2009 Jul; 67(1):E11-3. PubMed ID: 19590298
    [No Abstract]   [Full Text] [Related]  

  • 10. The care of a child with multiple trauma and severe anemia who was a Jehovah's Witness.
    Digieri LA; Pistelli IP; de Carvalho CE
    Hematology; 2006 Jun; 11(3):187-91. PubMed ID: 17325960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hemorrhagic shock when blood is not an option.
    Mackenzie CF; Morrison C; Jaberi M; Genuit T; Katamuluwa S; Rodriguez A
    J Clin Anesth; 2008 Nov; 20(7):538-41. PubMed ID: 19019664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury.
    Boshkov LK; Tredget EE; Janowska-Wieczorek A
    Am J Hematol; 1991 May; 37(1):53-4. PubMed ID: 2024641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of recombinant human erythropoietin in a Jehovah's Witness with a thermal injury.
    Deitch EA; Guillory D; Cruz N
    J Burn Care Rehabil; 1994; 15(1):42-5. PubMed ID: 8150842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluosol: therapeutic failure in severe anemia.
    Kale PB; Sklar GE; Wesolowicz LA; DiLisio RE
    Ann Pharmacother; 1993 Dec; 27(12):1452-4. PubMed ID: 8305774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature.
    Donahue LL; Shapira I; Shander A; Kolitz J; Allen S; Greenburg G
    Transfusion; 2010 Jul; 50(7):1561-7. PubMed ID: 20456679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin use in a Jehovah's Witness patient.
    Walton T; Macon EJ
    Ann Pharmacother; 2002 Apr; 36(4):729-30. PubMed ID: 11936087
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
    Ball AM; Winstead PS
    Pharmacotherapy; 2008 Nov; 28(11):1383-90. PubMed ID: 18956998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a hemoglobin substitute in the anemic Jehovah's Witness patient.
    Marelli TR
    Crit Care Nurse; 1994 Feb; 14(1):31-8. PubMed ID: 8194324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of recombinant human erythropoietin in a Jehovah's Witness.
    Koenig HM; Levine EA; Resnick DJ; Meyer WJ
    J Clin Anesth; 1993; 5(3):244-7. PubMed ID: 8318245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of perioperative acute anemia by human recombinant erythropoietin in a Jehovah's witness].
    Boursas M; Benhassine L; Paris F; Kempf J; Vuillemin F
    Ann Fr Anesth Reanim; 1997; 16(3):312-3. PubMed ID: 9732784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.